基本情報
- 標準SMILES
CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1- InChIKey
XBJBPGROQZJDOJ-UHFFFAOYSA-N- 分子式
- C17H18F3N3O3
- 平均分子量
- 369.34 g/mol
- 単同位体質量
- 369.1300261
概要
Fleroxacin is a fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria. It has a role as an antibacterial drug, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor and a topoisomerase IV inhibitor. It is a monocarboxylic acid, a member of quinolines, a difluorobenzene, a N-alkylpiperazine and a fluoroquinolone antibiotic.
名称と識別子
- 優先名称
- Fleroxacin
- IUPAC
- 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
名称と別名
名称をさらに表示
データベース識別子
- CAS
79660-72-3- PubChem CID
- 3357
- DTXSID
DTXSID1046714- ChEMBL
CHEMBL6273- ChEBI
CHEBI:31810- UNII
- N804LDH51K
- EC Number
- 677-525-2
- Nikkaji
- J23.768J
物性
構造計算による物性
- XLogP
- -0.1
- 極性表面積
- 64.1 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 9
- 回転可能結合数
- 4
- 重原子数
- 26
- 形式電荷
- 0
- 複雑度
- 595
実験および物理化学的性質
Drugs
Pharmaceuticals -> Antibiotics
Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use
Pharmaceuticals -> Listed in ZINC15
Dissociation Constants
8.8
5.5
5.5
8.2
安全と法規制
GHS分類
GHS Classification
Warning
H371 (100%): May cause damage to organs [Warning Specific target organ toxicity, single exposure]
P260, P264, P270, P308+P316, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
危険有害性情報
化学と産業
薬理情報
ATC Code
J - Antiinfectives for systemic use
QJ - Antiinfectives for systemic use
MeSH Pharmacological Classification
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.
用途と製造
関連反応
関連ノート
読み込み中…